SCHEMBL23309625

SCHEMBL23309625

Cc1csc(NC(=O)c2cc(F)nc(F)c2F)c1C#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 5/20 0.37
▸ KDM4E B2RXH2 5/20 0.37
▸ BRCA1 P38398 1/20 0.37
▸ ALDH1A1 P00352 10/20 0.36
▸ MEN1 O00255 6/20 0.36
▸ KMT2A Q03164 6/20 0.36
▸ PKM P14618 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ MAPT P10636 7/20 0.36
▸ SMN1; SMN2 Q16637 6/20 0.36
▸ TP53 P04637 5/20 0.36
▸ HPGD P15428 5/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ POLB P06746 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ GRM5 P41594 1/20 0.36
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309498 0.76 MEN1 (0.55) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL23309594 0.73 POLB (0.50) KDM4EALDH1A1KMT2AMAPK1NPC1
SCHEMBL23309614 0.71 LCK (0.45) ALDH1A1PKMMAPTSMN1; SMN2USP2
SCHEMBL23309521 0.71 GRM5 (0.51) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL11815528 0.70 IKBKB (0.39) HSD17B10KDM4EBRCA1ALDH1A1MEN1
SCHEMBL23309587 0.70 MAPT (0.47) KDM4EALDH1A1MEN1KMT2ATDP1
SCHEMBL23309636 0.70 EGLN1 (0.43) —
SCHEMBL23309621 0.69 RAB9A (0.50) HSD17B10KDM4EALDH1A1MEN1KMT2A
SCHEMBL23309730 0.69 KMT2A (0.47) KDM4EALDH1A1MEN1KMT2AMAPK1
SCHEMBL23309725 0.68 GAA (0.43) HSD17B10ALDH1A1HPGDMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL HSD17B10 1857/4885KDM4E 3438/4885BRCA1 3215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback